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Summary
Objectives: To investigate the importance of time in pregnancy and neonatal sex on
the association between maternal metabolic parameters and neonatal sum of
skinfolds.
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Methods: This was a longitudinal, secondary analysis of the vitamin D and lifestyle
intervention for gestational diabetes mellitus study, conducted in nine European
countries during 2012 to 2015. Pregnant women with a pre-pregnancy body mass
index (BMI) of ≥29 kg/m2 were invited to participate. We measured 14 maternal
metabolic parameters at three times during pregnancy: <20 weeks, 24 to 28 weeks,
and 35 to 37 weeks of gestation. The sum of four skinfolds assessed within 2 days
after birth was the measure of neonatal adiposity.
Results: In total, 458 mother-infant pairs (50.2% female infants) were included.
Insulin resistance (fasting insulin and HOMA-index of insulin resistance) in early
pregnancy was an important predictor for boys' sum of skinfolds, in addition to
fasting glucose and maternal adiposity (leptin, BMI and neck circumference)
throughout pregnancy. In girls, maternal lipids (triglycerides and fatty acids) in the
first half of pregnancy were important predictors of sum of skinfolds, as well as
fasting glucose in the second half of pregnancy.
Conclusions: Associations between maternal metabolic parameters and neonatal
adiposity vary between different periods during pregnancy. This time-dependency
is different between sexes, suggesting different growth strategies.
KEYWORDS

foetal growth, foetal programming, maternal health, metabolic syndrome, neonatal body
composition, pregnancy
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I N T RO DU CT I O N

increased in women with obesity and/or gestational diabetes (GDM)
already at 20 weeks of gestation or even before9,10; maternal insulin

Globally, in 2017 an estimated 38 million children under 5 years of

resistance in the first half of pregnancy is related to neonatal fat

age presented either overweight or obesity. This is a major public

percentage,7 and fasting glucose in the first trimester with the risk

1

health concern. Hence, strategies have to be developed to reduce

of a large-for-gestational age baby.11 Although these studies suggest

this burden and prevent childhood obesity. This requires a thorough

an influence of the early pregnancy period, surprisingly little is

identification and understanding of the underlying determinants.

known about temporal relations between maternal metabolic mea-

Maternal obesity in pregnancy is linked with the development of
2-5

sures and neonatal fat accrual.12

Although there is much interest

Female neonates are known to be more insulin resistant,13,14

in the relationship between maternal obesity and childhood adiposity,

which might explain why males are more affected by in utero expo-

maternal metabolic factors driving the increase in offspring adiposity

sure to gestational diabetes.9 Therefore, it is mandatory to assess

have not been fully understood.

temporal relations of maternal metabolism with neonatal adiposity in

neonatal and childhood adiposity.

The Hyperglycemia and Adverse Pregnancy Outcome study

a sex-dependent manner.

showed a continuous positive relationship of maternal glucose in

In this study, we investigated the association between maternal

the second trimester with measures of neonatal body fat.6 Findings

health measures at different times during pregnancy and neonatal

from the Healthy Start Study support this and, in addition, showed

sum of skinfolds in a sex-specific manner. We hypothesized that:

temporal changes in the association of glucose and neonatal fat,

(a) associations between maternal metabolic parameters and neonatal

with stronger associations in the second half of pregnancy com-

adiposity differ at different time points, and (b) these temporal differ-

pared to early pregnancy.7,8 However, other studies clearly indicate

ences are sex-specific. We tested these hypotheses in 458 mother-

that the influence of maternal phenotype on foetal growth can

infant pairs in the vitamin D and lifestyle intervention for gestational

already be demonstrated in the early pregnancy period: foetal

diabetes mellitus (DALI) study, a pan-European study originally

abdominal circumference, as proxy for foetal overgrowth, is

designed for the prevention of gestational diabetes.15
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METHODS

|

(SECA 888 and 877, SECA, UK) at baseline (<20 weeks), 24 to
28 weeks, and at 35 to 37 weeks of gestation. BMI was calculated as

2.1

Design and participants

|

weight in kilogram divided by the square of height in metres. Gestational weight gain was defined as the change in objectively measured

This is a longitudinal, secondary analysis of the DALI study, which was a

weight from pre-pregnancy to <20, <20 to 24-28 weeks and from

multicentre parallel randomized trial conducted in nine European countries

24-28 to 35-37 weeks. Neck circumference was obtained in a stand-

(Austria, Belgium, Denmark, Ireland, Italy, Netherlands, Poland, Spain and

ing relaxed upright position between mid-cervical spine and mid-

United Kingdom) during 2012 to 2015. The study was prospectively regis-

anterior neck, to within 1 mm.19

tered as a randomized clinical trial (RCT) with the primary aim to prevent

After fasting for 10 hours, blood was collected and mothers con-

gestational diabetes mellitus on November 21, 2011 (ISRCTN70595832).

sumed a 250 mL 75 g glucose drink (within a period of 5 minutes).

Local ethics committee approval and written informed consent of all

Further blood collections took place after 60 and 120 minutes. All the

women was obtained. Pregnant women with a pre-pregnancy body mass

samples were centrifuged and separated aliquots of plasma (1000 μL

index (BMI) of ≥29 kg/m2, <20 weeks of gestation, a singleton pregnancy

or 250 μL) placed in microrack tubes and stored at −20 C or −80 C in

and aged ≥18 years were invited to participate.16 Exclusion criteria

the central trial laboratory, prior to analysis, in Graz, Austria. The

17,18

included diagnosis with early gestational diabetes mellitus,

pre-

existing diabetes, and chronic medical conditions.

maternal concentrations of plasma fasting glucose, fasting insulin, triglycerides, free fatty acids and leptin were quantified. For insulin and
leptin commercially available Enzyme-Linked Immuno Sorbent Assays
were used. In the samples taken 60 and 120 minutes after glucose

2.2

Design and procedures

|

load, only glucose (1-hour glucose and 2-hour glucose) and insulin
(1-hour insulin and 2-hour insulin) were assessed. Fasting insulin resis-

The study was originally designed as an RCT with the following

tance was derived from homeostasis model assessment (HOMA-index

groups, pre-stratified for site: (a) healthy eating; (b) physical activity;

of insulin resistance – HOMA-IR).20 Insulin secretion after glucose

(c) healthy eating + physical activity; (d) healthy eating + physical

load were calculated with the Stumvoll first phase and Stumvoll sec-

activity + vitamin D; (e) healthy eating + physical activity + placebo;

ond phase validated equations.21

(f) vitamin D; (g) placebo, (h) control. Staff involved with measurements, but not participants, were blinded to the lifestyle intervention.
Both staff and participants were blinded to vitamin D intervention.

2.3.3

Covariates

|

For the purpose of this analysis, the data were analyzed as a longitudinal

baseline

Information on possible covariates was collected in the baseline ques-

(<20 weeks), at 24 to 28 and at 35 to 37 weeks of gestation. Since

cohort.

Maternal

measurements

took

place

at

tionnaire or from medical files: national site(s) of recruitment, maternal

16

methodology has been extensively described elsewhere,

only vari-

ables of interest will be detailed in this manuscript.

age, gestational age during pregnancy (<20, 24 to 28 and 35 to
37 weeks), maternal ethnicity (European or non-European descent),
maternal education (low, medium and high), smoking status at 35 to
37 weeks of gestation (yes/no), pre-pregnancy BMI and gestational

2.3
2.3.1

Measurements

|
|

age at birth.

Neonatal outcome
2.4

|

Statistical analyses

Triceps, subscapular, supra-iliac and quadriceps skinfolds were measured within 48 hours of birth with a Harpenden skinfold calliper

All analyses were performed in STATA version 13 for windows

(Baty, UK), and the values summed to obtain the primary neonatal

(StataCorp LP, College Station, Texas) and a 5% type I error rate

outcome measure, the sum of skinfolds. Each skinfold measurement

was used for the analyses. We have 80% statistical power to

was measured twice and if a difference of more than 0.2 mm was reg-

detect associations with small effect sizes (f2 = 0.04) considering

istered, a third measurement was performed and the average of the

the number of participants evaluated (n = 458) and the number of

three was taken. The neonatal age at the measurement was the time

exposures and confounding variables in each of our models.

between birth and measurements, which was registered in hours.

Skewed variables were log-transformed before analyses (fasting
insulin, 1-hour insulin, 2-hour insulin, HOMA-IR, Stumvoll first
phase, Stumvoll second phase, triglycerides, leptin and BMI). Inde-

2.3.2 | Maternal metabolic and adiposity
parameters

pendent t tests were performed to evaluate descriptive differences
in the mother's metabolic and adiposity parameters for each pregnancy period in relation to their child's sex (results shown in

Maternal height was determined at baseline with a stadiometer (SECA

Table 1). Independent t tests also evaluated sex-differences in neo-

206; SECA, UK). Women were weighed on calibrated electronic scales

natal skinfolds.

85.48

60.87

2.57

1639.26

421.81

1.23

0.63

33.63

36.18

34.13

2.02

Fasting insulin (μU/mL)

1-h insulin (μU/mL)

2-h insulin (μU/mL)

HOMA-IR ([μU/mL]*[mmol/L])

Stumvoll first phase (pmol/L)

Stumvoll second phase (pmol/L)

Triglycerides (mmol/L)

Fatty acids (mmol/L)

Leptin (pg/mL)

Neck circumference (cm)

BMI (kg/m2)

Gestational weight gain (kg)

1.11

3.92

1.01

2.06

1.03

0.23

1.02

1.02

1.02

1.03

1.05

1.05

1.03

1.84

34.17

36.21

34.16

0.64

1.26

416.57

1616.57

2.68

53.62

84.98

13.12

5.81

6.80

4.48

1.01

2.17

1.03

0.21

1.02

1.02

1.02

1.03

1.06

1.05

1.03

1.18

1.47

0.36

.64

.91

.89

.74

.48

.48

.70

.68

.40

.43

.93

.46

.45

.15

.39

4.06

35.63

36.29

32.59

0.59

1.76

449.52

1740.14

2.84

72.44

112.62

13.98

6.17

7.56

4.54

3.28

1.01

2.12

1.03

0.23

1.02

1.02

1.02

1.03

1.05

1.04

1.03

1.25

1.70

0.40

SD

3.92

35.64

36.28

34.29

0.58

1.70

482.72

1872.26

3.15

76.22

124.58

15.46

6.15

7.77

4.61

Mean

Girls

2.74

1.01

2.23

1.04

0.19

1.02

1.02

1.03

1.03

1.05

1.04

1.03

1.27

1.60

0.43

SD

2556.15
650.25

.04
.03

.63

.97

.98

.30

.37

3.82

36.88

36.53

32.07

0.59

2.21

3.31

.03

.25

107.99

.47

157.47

17.05
.09

6.44

.02

7.93

4.47

Mean

.87

.19

.07

P

Boys

35-37 weeks

2.78

1.01

2.17

1.04

0.23

1.03

1.03

1.03

1.04

1.06

1.05

1.04

1.25

1.55

0.45

SD

3.76

36.96

36.60

33.02

0.61

2.13

680.23

2676.00

3.62

110.62

166.11

17.97

6.49

8.12

4.56

Mean

Girls

2.82

1.01

2.22

1.04

0.21

1.03

1.03

1.03

1.05

1.06

1.05

1.04

1.12

1.45

0.43

SD

.82

.84

.74

.59

.40

.33

.30

.31

.16

.75

.43

.37

.70

.25

.05

P

Note: P value from independent t test; Fasting insulin, 1-hour insulin, 2-hour insulin, HOMA-IR, Stumvoll first phase, Stumvoll second phase, triglycerides, leptin and BMI were log-transformed for the analyses,
but the values in the table were exponentiated for clarity.
Abbreviation: BMI, body mass index.

5.72

12.69

2-h glucose (mmol/L)

1.38

4.61

6.60

0.38

4.58

1-h glucose (mmol/L)

Mean

Fasting glucose (mmol/L)

P

Mean

Mean

Maternal parameters

SD

Boys

Girls

Boys
SD

24-28 weeks

Mean and SD of the mothers' variables included in the main analyses for different gestational time and stratified by sex

<20 weeks

TABLE 1
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We conducted principal component factor analyses for each mea-

2.5

Supplementary analysis

|

surement time during pregnancy to group the exposures with shared
variances in the same factor. All components from the mother's health

Multiple linear multilevel analyses tested the association between

profile were included in the factor analyses: fasting glucose, 1-hour

each of the maternal measurements during pregnancy and neonatal

glucose, 2-hour glucose, fasting insulin, 1-hour insulin, 2-hour insulin,

sum of skinfolds (see Table S2). Sex-effects were estimated by inclu-

HOMA-IR, Stumvoll first phase, Stumvoll second phase, triglycerides,

sion of an interaction term between the exposures and sex. All ana-

free fatty acids, leptin, neck circumference, BMI and gestational

lyses were adjusted for intervention group, site of recruitment,

weight gain. Independent of the pregnancy period, the scree plot

maternal ethnicity, education, BMI (except when BMI was the expo-

determined that four factors were relevant to be estimated. Thus, four

sure), age, smoking status, gestational age during pregnancy (<20,

factors were estimated for each time during pregnancy by the follow-

24 to 28 and 35 to 37 weeks), gestational age at birth (weeks) and

ing criteria:

neonatal age at measurement (hours post birth). The cluster structure
of data was also taken into account with individuals nested into the

1. Independent of the time during pregnancy, each factor should be
composed of the same variables;
2. Each factor was composed of variables with high loading factors
(≥0.4) in at least two measuring points after varimax rotation of

site of recruitment. We used robust correction for estimating the
standard errors and used the Bonferroni adjustment for multiple testing. Analyses with triglycerides and fatty acids as exposures were further adjusted for HOMA-IR.

the correlation matrix;
3. Components with high loading factors (≥0.4) in more than one factor were only included in the factor with the highest loading

3

|

RE SU LT S

factor;
4. Factors were estimated using the linear regression prediction
score.

In total, 458 mother-infant pairs (50.2% female infants) were included
in the study. On average, the mothers were 32.1 (±5.3) years of age
and their infants were measured 19.9 (±30.5) hours after birth. Mothers

At all three time points during pregnancy, factor 1 was composed

gave birth after 39.7 (±1.4) weeks of gestation, and most mothers per-

of fasting insulin and HOMA-IR (representing insulin resistance); fac-

ceived themselves as of European descent (84.6%) and did not smoke

tor 2 was composed of 1-hour insulin, 2-hour insulin, Stumvoll first

during pregnancy (85.6%). More than half of the mothers (57.6%)

phase and Stumvoll second phase (representing insulin response); fac-

reported high educational level, whereas 32.0% reported medium edu-

tor 3 was constituted of 1-hour glucose and 2-hour glucose (rep-

cational level. Neonatal boys exhibited lower sum of skinfolds com-

resenting glucose tolerance), and, factor 4 was composed of leptin,

pared to girls (Mean sum of skinfoldsboys = 20.3 mm [±5.2]; Mean sum

BMI and neck circumference (representing maternal adiposity).

of skinfoldsgirls = 21.5 mm [±5.4]; P = .02).

Table S1 presents the cumulative variance of each factor in the three
periods of gestation. Fasting glucose, triglycerides, free fatty acids and
gestational weight gain did not have a high loading factor for any of
the factors, nor did they built a separate factor, and were not included

3.1 |
points

Maternal metabolic parameters at three time

in any of the factors. Thus, they were analyzed as single exposures in
relation to neonatal sum of skinfolds.

Table 1 describes the unadjusted sex-differences in the mothers'

The association of each resulting factor from the mother's health

metabolic profile for each gestational time. In the first measurement

profile with neonatal sum of skinfolds was assessed using linear multi-

prior to 20 weeks of gestation, no differences were observed in

level analyses, adjusted for intervention group, site of recruitment,

maternal metabolic measurements between mothers of boys and

gestational age during pregnancy, gestational age at birth, neonatal

girls. At 24 to 28 weeks of gestation, mothers of girls had higher

age at measurement, maternal ethnicity, maternal education, BMI

fasting insulin, HOMA-IR and Stumvoll first and second phases com-

(except in factor 4 since BMI was part of this factor), maternal age,

pared to mothers of boys. At 35 to 37 weeks of gestation, mothers

smoking status and the cluster structure. Sex-effects were estimated

of girls had higher fasting glucose compared to those of boys

by inclusion of an interaction term between the factor and sex. We

(Table 1).

used robust correction for estimating the standard errors and estimated P-values using the Bonferroni adjustment for multiple testing.
The association between the mother's health profile not included in
any of the factors (fasting glucose, triglycerides, free fatty acids and

3.2 | Associations of maternal metabolic
parameters with neonatal adiposity

gestational weight gain) and neonatal sum of skinfolds was evaluated
following the same procedure abovementioned. Note that we tested

Associations of the four factors, and fasting glucose, triglycerides,

the same analysis replacing BMI for gestational weight gain as a con-

fatty acids and gestational weight gain at the three time points with

founder. The conclusions were similar, so we only present the results

neonatal adiposity are described in Table 2. Factor 1 (fasting insulin

with BMI adjustment.

and HOMA-IR) at <20 weeks of gestation was associated with boys'

6 of 11
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sum of skinfolds, and with girls' sum of skinfolds at 35 to 37 weeks of

that associations of metabolic parameters with neonatal adiposity

gestation. Factor 2 (1-hour insulin, 2-hour insulin, Stumvoll first phase,

change between different time-periods and differ between sexes. We

Stumvoll second phase) was associated with boys' sum of skinfolds at

demonstrate a complex pattern of metabolic metabolism and its asso-

35 to 37 weeks of gestation, and no association was found of this fac-

ciation with neonatal fat measured as sum of skinfolds, as illustrated

tor with girls' sum of skinfolds. Factor 3 (1-hour glucose and 2-hour

in Figure 2. In summary, insulin resistance in early pregnancy is an

glucose) at 35 to 37 weeks of gestation was associated with boys'

important predictor for boys' sum of skinfolds, in addition to fasting

sum of skinfolds and at 24 to 28 and 35 to 37 weeks of gestation with

glucose throughout pregnancy. In girls, maternal lipids in the first half

girls' sum of skinfolds. Finally, factor 4 (leptin, BMI and neck circum-

of pregnancy period play a role for sum of skinfolds, as well as fasting

ference) was associated with boys' sum of skinfolds in all pregnancy

glucose in the second half of pregnancy.

periods, but not with girls' sum of skinfolds (Figure 1).

In both sexes, the early pregnancy period is relevant for neonatal

Fasting glucose at <20, 24 to 28 and 35 to 37 weeks of gestation

adiposity, although for different metabolic parameters (ie, insulin

was associated with boys' sum of skinfolds, and at 24 to 28 and 35 to

resistance in boys and lipid levels in girls). Although a later interven-

37 weeks of gestation with girls' sum of skinfolds. Triglycerides at

tion was effective in reducing neonatal adiposity,22 our data suggest

<20 weeks were positively associated with the sum of skinfolds in

that ideally maternal metabolism shall be normalized already early in

girls, and 35 to 37 weeks with sum of skinfolds of boys. Fatty acids

pregnancy to reduce the risk of neonatal adiposity. Hence, interven-

were associated with sum of skinfolds in girls at <20 and 24 to

tions beginning prior to or in very early pregnancy might be even

28 weeks. Gestational weight gain at <20 weeks was positively asso-

more effective than those initiated later, and achieved a 9% reduction

ciated with boys' sum of skinfolds (Table 2). Table S2 describes the

in neonatal fat.22 Our results also indicate that both types of nutrients,

associations of maternal parameters that were included in the factors

glucose and lipids, are related to neonatal adiposity, although associa-

with neonatal adiposity.

tions are time- and sex-dependent. This argues for future time- and
sex-specific studies to delineate metabolic pathways between maternal adiposity, insulin resistance, the different nutrients and neonatal

4

|

DISCUSSION

adiposity.
The physiological pathways influencing neonatal adiposity origi-

The main aim of the present study was to identify the effect of some

nate from maternal insulin resistance, which is higher with increasing

maternal metabolism on neonatal skinfolds at different times in preg-

maternal BMI. Indeed, in the Healthy Start Study7 maternal insulin

nancy in a sex-dependent manner. Results confirmed our hypotheses

resistance in the first half of pregnancy was an independent predictor

T A B L E 2 Multilevel regression coefficients of the association between maternal health profile components and child's sum of skinfolds (mm)
by sex in three periods of gestation
Boys

Girls

<20 weeks

24-28 weeks

35-37 weeks

<20 weeks

24-28 weeks

35-37 weeks

Maternal parameters

β

P

β

P

β

P

β

P

β

P

β

P

Factor 1
Fasting insulin and HOMA-IR

1.091

.006

.130

.713

.445

.103

.536

.094

.339

.372

.347

.044

Factor 2
1-h and 2-h insulin, and Stumvoll first
and second phases

.458

.163

.305

.256

.673

.009

.389

.228

.449

.215

.208

.521

Factor 3
1-h and 2-h glucose

.384

.362

−.241

.617

1.083

.022

.529

.280

1.387

.012

1.520

.020

Factor 4
Leptin, BMI and neck circumference

1.136

.004

1.114

.008

1.342

.008

.349

.196

.505

.100

.596

.152

Fasting glucose (mmol/L)

1.792

<.001

1.406

.011

2.085

.019

−.045

.968

2.475

.008

1.361

.035

Triglycerides (log)

1.428

.423

.235

.854

2.740

.005

2.005

.031

1.907

.119

1.395

.235

Fatty acids (mmol/L)

1.555

.152

.462

.787

1.179

.544

3.886

<.001

4.942

.011

−1.678

.203

Gestational weight gain (kg)

.197

.033

−.003

.975

.059

.645

.021

.646

.125

.345

.010

.526

Note: Adjusted for intervention group, site of recruitment, maternal ethnicity, education, BMI (except when BMI was the exposure), age and smoking
status, gestational age during pregnancy (weeks), gestational age at birth (weeks) and neonatal age at measurement (hours), and cluster structure
(individuals nested in site of measurement). Besides the aforementioned adjustments, HOMA-index was also an adjustment when triglycerides and fatty
acids were the exposures. P values are Bonferroni adjusted.
Abbreviation: BMI, body mass index.
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(A)2.0

Boys

(B) 1.4

Girls

Girls

1.2

Factor 1 - Fasting Insulin and HOMA-IR
1.5

1.0
1.09

0.8

1.0

0.67
0.54

0.45

0.5

0.34
0.35

0.6

β (95% CI)

β (95% CI)

Boys

Factor 2 - One-hour Insulin; Two-hour Insulin; Stumvoll 1st phase; Stumvoll 2nd phase

0.46

0.45

0.4
0.39

0.31

0.2

0.21

0.13

0.0

0.0
-0.2

-0.5

-0.4
-1.0

(C)

<20 weeks

24-28 weeks

Boys

-0.6

35-37 weeks

<20 weeks

(D)

Girls

3.0

24-28 weeks

Boys

35-37 weeks

Girls

2.5

Factor 3 - One-hour Glucose; Two-hour Glucose

Factor 4 - Leptin; BMI; Neck circumference

2.5
2.0
2.0
1.52

1.39

1.08

1.0
0.5

0.53
0.38

0.0

1.5
β (95% CI)

β (95% CI)

1.5

1.34
1.11

1.14

1.0
0.51

0.5
-0.24

0.60

0.35

-0.5
0.0
-1.0
-1.5

<20 weeks

24-28 weeks

35-37 weeks

-0.5

<20 weeks

24-28 weeks

35-37 weeks

F I G U R E 1 Multilevel regression coefficients of the association between (A) factor 1 (fasting insulin and HOMA-index); (B) factor 2 (1-hour
insulin, 2-hour insulin, Stumvoll phase 1 and Stumvoll phase 2); (C) factor 3 (1-hour glucose and 2-hour glucose) and (D) factor 4 (leptin, BMI and
neck circumference) and neonatal sum of skinfolds (mm) by sex in three periods of gestation. Adjusted intervention group, site of recruitment,
gestational age during pregnancy, gestational age at birth, neonatal age at measurement, maternal ethnicity, maternal education, body mass index
(BMI), except in the factor 4 since BMI was part of this factor, maternal age, smoking status and cluster structure (individuals nested in site of
measurement)

of neonatal adiposity. This is in principle in line with our findings of

various populations,7,24-26 the role of fasting glucose for neonatal adi-

insulin resistance (represented by factor 1) in early pregnancy playing

posity in women with obesity is a novel finding to the best of our

a role, but in our study, this was limited to boys only. Later in preg-

knowledge. Maternal fasting glucose was a driver of fat accretion

nancy, the positive association of insulin resistance with neonatal adi-

throughout pregnancy in boys and mainly in later pregnancy in girls.

posity was found in both boys and girls. The strong determining role

The sex difference in early pregnancy might explain why the Healthy

of early insulin resistance for neonatal adiposity is not without prece-

Start Study7 only found an association of fasting glucose after

dent and extends to the pre-pregnancy period, in which insulin resis-

20 weeks of gestation, but not before, with neonatal adiposity. The

tance had the strongest association with neonatal fat mass, more so

reasons for the sex-difference in the timing of the association of

than insulin resistance in late pregnancy.23 However, neither of those

fasting glucose with neonatal fat remain speculative. The glucose steal

previous studies tested for sex differences in this association or, spe-

phenomenon posits foetal hyperinsulinemia, the main driver of fat

cifically, in pregnant women with obesity. Two studies that analyzed

accretion, as the result of maternal hyperglycemia from early on.27 A

24,25

boys and girls separately

found associations of insulin resistance

late in pregnancy with measures of adiposity in girls, but not in boys,

sex-difference in the timing of the glucose steal may be one explanation for our findings, but this remains to be studied.

which is not fully in line with our findings. The different finding might

Interestingly, independent of maternal insulin sensitivity, lipids in

be explained by differences in maternal BMI or the participants' level

the first half of the pregnancy period were associated with sum of

of glucose tolerance, since those other studies were not limited to

skinfolds in girls. In boys, only triglycerides at 35 to 37 weeks were

women with obesity without GDM at baseline, as in our study

related with neonatal skinfolds. This sex interaction in the association

24,25

of lipids with neonatal skinfolds might explain the lack of association

sample.

The pathway from insulin resistance to neonatal adiposity might
8

be through one of the nutrients glucose or lipids. Although found in

in previous studies not distinguishing between sexes.7,19,20 To complicate matters further, the association of maternal lipids with neonatal
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Insulin resistance
Glycaemia
Lipids

Boys skinfolds

Higher
Importance

Medium
Importance

Weak or No
Importance

<20 weeks

24-28 weeks
Pregnancy period

35-37 weeks

Insulin resistance
Glycaemia
Lipids

Girls skinfolds

Higher
Importance

Medium
Importance

Weak or No
Importance

<20 weeks

FIGURE 2

24-28 weeks
Pregnancy period

35-37 weeks

Summarized visualization of the degree of importance of some maternal parameters in relation to neonatal sum of skinfolds by sex

adiposity might also depend on maternal metabolic status and/or
7

is a powerful method for establishing causal exposure-outcome rela-

weight. Crume et al observed that maternal triglycerides, in middle to

tions. The present results call for using this method in a sex-specific

late pregnancy, were associated with neonatal fat mass only in women

manner, and at the same time distinguishing between women with

with obesity before pregnancy. In a study including women with a

different weight status. Moreover, neonatal fat percentage is the rele-

normal glucose metabolism and those with gestational diabetes,

vant offspring outcome more sensitive to in utero influences, and

maternal lipids, triglycerides and free fatty acids in late pregnancy

hence, more variable than birth weight.

were positively associated with neonatal fat mass only in women with

While analysis of the insulin secretory response (factor 2) did not

gestational diabetes, but not in women with normal glycaemia.28 This

result in a clear picture, glucose tolerance (factor 3) at the end of preg-

complex interaction between maternal phenotype, neonatal sex and

nancy was related to neonatal adiposity for boys and girls. Conflicting

maternal lipid profile could be a reason why in a Mendelian randomi-

results have been found on the association of glucose tolerance with

zation approach no causal effect of maternal triglyceride concentra-

neonatal adiposity. Most,7,25,30 but not all,23 studies reported positive

29

tions on offspring birth weight was found.

Mendelian randomization

associations. None of those assessed sex differences, and importantly,
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only one study evaluated exclusively pregnant women with obesity.

prevalence of pregnant women with obesity is alarming,44 studying

Thus, more information is needed to draw any conclusions on the role

the consequences of maternal obesity is of public health relevance. A

of insulin secretory response or glucose tolerance for neonatal

strength of our study is the measurements of maternal metabolic

adiposity.

parameters at three time points in pregnancy. Without this elaborate

Maternal adiposity, mostly assessed by the pre-pregnancy BMI,
has

been

related

4,5,25,31-33

studies,

with

neonatal

adiposity

in
34

numerous

approach, identification of time-dependent effects had not been
possible.

We found

DALI study was designed to evaluate the effects of different

maternal adiposity to be associated with neonatal adiposity in boys

interventions on preventing gestational diabetes in pregnant women

throughout pregnancy, but no association was found in girls.

with obesity. Although we adjusted the analyses for the various inter-

Although, when analyzed individually, maternal BMI in the second half

ventions, we cannot fully exclude a minor influence on the results.

of pregnancy period was associated with the girls' adiposity. Different

While more direct measures of neonatal adiposity by for example, air

from many of the previously mentioned studies, we only had women

displacement plethysmography, would have been preferred, we

with obesity in our sample, which might have precluded finding strong

recently reported an association of sum of skinfolds with cord blood

associations with maternal adiposity. Reports on sex differences in

leptin in this cohort,22 supporting the validity of the skinfold measures

the association of maternal adiposity and neonatal adiposity are con-

as proxy for neonatal adiposity.

although one reported no association.

flicting: Some find associations only in boys,35 but other studies only
in girls.36,37 Prior studies in pregnant women with diabetes have
reported an interaction of foetal sex with a number of maternal vari-

5
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CONC LU SION

ables in the prediction of large or small-for-gestational age new-borns
but results are not comparable since the outcome variable was not

Our results show time-dependent associations of maternal metabolic

new-born adiposity and maternal variables did not include lipids or

parameters with neonatal adiposity. Importantly, and a novel key

insulin sensitivity.38

result, we demonstrate that this time-dependence varies between
sexes. Thus, the study highlights the urgent need for inclusion of neonatal sex in all analyses, not as confounder, but as major determinant

4.1

|

and modifying factor. This has been recommended previously.45,46

Sex and time differences

The present study can inform future studies to include larger sample
Conceptually, male and female foetuses follow different growth strat-

sizes, because of the sex differences, but also measurements of

egies in utero.39,40 Mechanisms are not well understood, but male

maternal metabolism at more than one time point during pregnancy.

embryos have more rapid cell divisions compared to females,41 which
could lead to a more rapid growth.39,40 Their higher growth rate might
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